Prednisone for rheumatoid arthritis: The detriment of the doubt;Prednison bij reumatoïde artritis: het nadeel van de twijfel

Nederlands Tijdschrift voor Geneeskunde

Volumn 156, Issue 32, 2012, Pages

  Boers, Maarten ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

NOTE; RHEUMATOID ARTHRITIS;

EID: 84873580912     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Hench PS. The reversibility of certain rheumatic and non-rheumatic conditions by the use of cortisone or of the pituitary adrenocorticotropic hormone. Nobel Lecture. December 11, 1950.
2. Sokka T, Kautiainen H, Toloza S, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007;66:1491-6. (Pubitemid 350032658)
3. Bakker MF, Jacobs JW, Welsing PM, et al. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Int Med. 2012;156:329-39.
4. Kirwan JR, Bijlsma JW, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007;(1):CD006356.
5. Van Tuyl LH, Boers M, Lems WF, et al. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis. Ann Rheum Dis. 2010;69:807-12.